Join
Live feed
·
INSIDERFilingvia Quantisnow
Tenaya Therapeutics Inc. logo

Chief Executive Officer Ali Faraz sold $2,690 worth of shares (3,390 units at $0.79), decreasing direct ownership by 0.76% to 440,014 units (SEC Form 4) (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.
TNYA· Tenaya Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNYA (Tenaya Therapeutics Inc.) and more on Quantisnow.